Role of glucagon in the pathogenesis of diabetes: The status of the controversy
- 1 November 1978
- journal article
- review article
- Published by Elsevier in Metabolism
- Vol. 27 (11) , 1691-1709
- https://doi.org/10.1016/0026-0495(78)90291-3
Abstract
No abstract availableThis publication has 83 references indexed in Scilit:
- The effect of intraportal and peripheral infusions of glucagon on insulin and glucose concentrations and glucose tolerance in normal manDiabetologia, 1977
- Metabolic Effects of Somatostatin in Maturity-Onset DiabetesNew England Journal of Medicine, 1977
- INHIBITION OF CHOLECYSTOKININ-PANCREOZYMIN RELEASE BY SOMATOSTATINThe Lancet, 1977
- Ketoacidosis in Pancreatectomized ManNew England Journal of Medicine, 1977
- “Somatostatinoma”: A Somatostatin-Containing Tumor of the Endocrine PancreasNew England Journal of Medicine, 1977
- Glucagon levels in normal and diabetic subjects: Use of a specific immunoabsorbent for glucagon radioimmunoassayDiabetologia, 1977
- INFLUENCE OF SOMATOSTATIN ON CARBOHYDRATE DISPOSAL AND ABSORPTION IN DIABETES MELLITUSThe Lancet, 1976
- Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.Journal of Clinical Investigation, 1976
- The Effect of Somatostatin on Release and Insulinotropic Action of Gastric Inhibitory PolypeptideCanadian Journal of Physiology and Pharmacology, 1975
- DIRECT INHIBITION OF GASTRIC ACID AND PEPSIN SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN CATSThe Lancet, 1975